Literature DB >> 10543311

Apoptosis in congestive heart failure induced by viral myocarditis in mice.

T Yamada1, A Matsumori, W Z Wang, N Ohashi, K Shiota, S Sasayama.   

Abstract

It has recently been speculated that progressive deterioration of left ventricular function in chronic heart failure is due to the ongoing loss of viable cardiac myocytes. However, as there is little direct evidence of significant apoptosis contributing to the pathogenesis in cardiac myocytes in vivo, the significance of apoptosis in heart failure remains to be clarified. We investigated the role of apoptosis in heart failure induced by encephalomyocarditis virus myocarditis. DBA/2 mice were inoculated with the virus (day 0), then killed, and their hearts were extracted 3 to 28 days later. Internucleosomal DNA fragmentation, chromatin binding dye staining, and in situ terminal transferase deoxyuridine triphosphate (dUTP) end-labeling were used to detect apoptosis. Internucleosomal DNA fragmentation (DNA ladder) was clearly demonstrated on days 5 to 14 in the virus-infected hearts when myocardial necrosis and infiltration of mononuclear cells were prominent in the hearts. Apoptotic cells demonstrated morphological changes typical of apoptosis (condensation of chromatin and nuclear fragmentation). Both Fas antigen and Fas ligand immunoreactivity were detected in the infiltrating mononuclear cells. The in situ terminal transferase dUTP end-labeling method demonstrated condensed nuclei of infiltrating mononuclear cells on day 7. However, nuclei of cardiac myocytes surrounded by the cellular infiltration were absent. The main source of apoptotic cells in the heart in mice with viral myocarditis appeared to be the infiltrating mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543311     DOI: 10.1007/bf02481740

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  45 in total

1.  Apoptosis participates in cellularity regulation during rat aortic intimal thickening.

Authors:  M L Bochaton-Piallat; F Gabbiani; M Redard; A Desmoulière; G Gabbiani
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

2.  Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure.

Authors:  V G Sharov; H N Sabbah; H Shimoyama; A V Goussev; M Lesch; S Goldstein
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

3.  Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.

Authors:  H Suzuki; A Matsumori; Y Matoba; B S Kyu; A Tanaka; J Fujita; S Sasayama
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

4.  An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.

Authors:  A Matsumori; C Kawai
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

5.  Immunologic identification of lymphocyte subsets in experimental murine myocarditis with encephalomyocarditis virus. Different kinetics of lymphocyte subsets between the heart and the peripheral blood, and significance of Thy 1.2+ (pan T) and Lyt 1+, 23+ (immature T) subsets in the development of myocarditis.

Authors:  C Kishimoto; K Kuribayashi; K Fukuma; T Masuda; N Tomioka; W H Abelmann; C Kawai
Journal:  Circ Res       Date:  1987-11       Impact factor: 17.367

6.  Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs.

Authors:  Y Liu; E Cigola; W Cheng; J Kajstura; G Olivetti; T H Hintze; P Anversa
Journal:  Lab Invest       Date:  1995-12       Impact factor: 5.662

7.  Right ventricular aneurysms complicating encephalomyocarditis virus myocarditis in mice.

Authors:  A Matsumori; C Kishimoto; C Kawai; S Sawada
Journal:  Jpn Circ J       Date:  1983-11

8.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

9.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.

Authors:  Y J Geng; P Libby
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 10.  Cell death in the failing heart: role of an unnatural growth response to overload.

Authors:  A M Katz
Journal:  Clin Cardiol       Date:  1995-09       Impact factor: 2.882

View more
  7 in total

Review 1.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

2.  Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.

Authors:  Sally Huber; Cuixia Shi; Ralph C Budd
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 3.  The encephalomyocarditis virus.

Authors:  Margot Carocci; Labib Bakkali-Kassimi
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

4.  Molecular Aspects of Myocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.663

5.  Decreased autophagy: a major factor for cardiomyocyte death induced by β1-adrenoceptor autoantibodies.

Authors:  L Wang; H Hao; J Wang; X Wang; S Zhang; Y Du; T Lv; L Zuo; Y Li; H Liu
Journal:  Cell Death Dis       Date:  2015-08-27       Impact factor: 8.469

6.  Honokiol Protects against Anti-β1-Adrenergic Receptor Autoantibody-Induced Myocardial Dysfunction via Activation of Autophagy.

Authors:  Xi-Qing Wei; Hong-Sheng Zhang; Guang-He Wei; Jin-Guo Zhang; Yan-Yan Du; Hong-Yong Tan; Jun Yang
Journal:  Oxid Med Cell Longev       Date:  2018-07-18       Impact factor: 6.543

7.  Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis.

Authors:  Ge Li-Sha; Liu Li; Zhou De-Pu; Shi Zhe-Wei; Gu Xiaohong; Chen Guang-Yi; Li Jia; Lin Jia-Feng; Chu Maoping; Li Yue-Chun
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.